Skip to content

Clinical trials

Adenoma, Islet Cell trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenoma, Islet Cell Country / region: Italy Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20111
20141
20191
20201
20211
20221
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting3
Unknown status3
Active, not recruiting2
Terminated2
Completed1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Institute of Oncology2
Azienda Ospedaliera Universitaria Integrata Verona1
Exelixis1
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano1
Francesco De Cobelli1
IRCCS San Raffaele1
Massimo Falconi1
Merck Sharp & Dohme LLC1
National Cancer Institute (NCI)1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenoma, Islet Cell11
Neoplasm Metastasis2
Neuroendocrine Tumors2
Carcinoid Tumor1
Gastrinoma1
Glucagonoma1
Insulinoma1
Lung Neoplasms1
Neoplasms1
Neuroectodermal Tumors, Primitive1

Trials

Showing 26 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.